Pulmicort Respules
Product Images NDC 54868-5621

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Pulmicort Respules (NDC 54868-5621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pulmicort Respules 0.5mg/2ml (30 single dose respules ampule carton)

Label for PULMICORT RESPULES 0.5MG/2ML, distributed by Physicians Total Care, Inc. The label includes lot number, expiration date, and a barcode. The product is indicated by the NDC code 54068-5621-0 and manufactured by AstraZeneca LP.*

FDA Label Image

Pulmicort Respules 0.25mg/2ml (30 single dose respules ampule carton)

Label for PULMICORT RESPULES 0.25MG/2ML by Physicians Total Care, Inc. The label includes lot and expiration date information along with a barcode.*

FDA Label Image

Figure 1 (Pulmicortrespules Figone)

A line graph showing mean change from baseline in nighttime asthma symptoms over 12 weeks for four groups: placebo, 0.25 mg once daily, 0.5 mg once daily, and 1.0 mg once daily. The x-axis shows weeks in intervals of 2, and the y-axis shows symptom change from 0 to -0.6. All treatment groups show improvement compared to placebo over time.*

FDA Label Image

Figure Three (Pulmicortrespules Figthree)

A line graph showing year-on-year change in nightly asthma symptoms for PULMICORT RESPULES at various dosages (0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 1.0 mg once daily) compared with placebo over a 12-week period. The x-axis represents time from baseline to week 12 in intervals, and the y-axis represents change in symptoms.*

FDA Label Image

Figure 2 (Pulmicortrespules Figtwo)

A line graph showing mean change from baseline in nighttime awakenings over weeks 0 to 12 for three groups: placebo, 0.25 mg twice daily, and 0.5 mg twice daily. The vertical axis ranges from -3.5 to 0.1 and the horizontal axis shows time intervals.*

FDA Label Image

Figure 4 (Pulmicortrespules Figurefour)

An instructional illustration showing a person holding an inhaler with one hand while using the other hand to load a medicine ampule into the device. The image demonstrates the preparation step for using PULMICORT RESPULES, a respiratory medication by Physicians Total Care, Inc.*

FDA Label Image

Figure 1 (Pulmicortrespules Figureone)

An instructional line drawing showing a person's hands preparing blister packaging by peeling back a protective foil strip to expose round doses, likely for PULMICORT RESPULES inhalation suspension vials.*

FDA Label Image

Figure 3 (Pulmicortrespules Figurethree)

Instructional illustration showing a person holding a medicinal ampule with one hand while twisting off the top with the other hand, demonstrating how to open a dose of PULMICORT RESPULES.*

FDA Label Image

Figure 2 (Pulmicortrespules Figuretwo)

An instructional illustration showing a hand holding a small bottle or ampule, with an arrow indicating a twisting motion to open or activate the bottle. The image is likely demonstrating how to use PULMICORT RESPULES liquid medication for inhalation.*

FDA Label Image

Structural Formula (Pulmicortrespules Firstimage)

Chemical structure of the active ingredient in PULMICORT RESPULES. The diagram shows molecular bonds and atomic arrangements typical for corticosteroid compounds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.